Sort
30,917 grants matching “tumor microenvironment”
Lipids and Myeloid Cell Function in Cancer
$356,333Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2013 · CA
Core 2: Animal Models
$356,287Stefan Niewiesk · Ohio State University · P01 · FY2020 · CA
Core 2: Animal Models
$356,287Stefan Niewiesk · Ohio State University · P01 · FY2021 · CA
Regulation of Tumorigenesis by the Perk Kinase
$356,256J. Alan Diehl · University Of Pennsylvania · P01 · FY2013 · CA
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
$356,167Damian J. Green · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Role of Bone Microenvironment in Tax Induced Malignancies
$356,146Katherine M Weilbaecher · Ohio State University · P01 · FY2012 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$356,143Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
$356,129Andrei Goga · University Of California, San Francisco · R01 · FY2019 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$356,129Hideho Okada · University Of California, San Francisco · R01 · FY2019 · CA
Proteases in Prostate Cancer Bone Metastasis
$356,113Michael L Cher · Wayne State University · R01 · FY2007 · DK
Targeting the vasculature to enhance anti-tumor immunity
$356,108Andrew Carl Dudley · University Of Virginia · R01 · FY2022 · CA
Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
$356,087Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2015 · GM
Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
$356,087Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2017 · GM
Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
$356,087Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2018 · GM
Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
$356,087Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2016 · GM
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$356,084James A Wells · University Of California, San Francisco · R01 · FY2022 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$356,084James A Wells · University Of California, San Francisco · R01 · FY2023 · CA
A Single Conical Tube Device for Precision CAR-T Cells Manufacturing
$356,057Yuguo Lei · Pennsylvania State University, The · R33 · FY2021 · CA
Preoperative exercise therapy for surgery triggered inflammation
$355,967Hai Huang · Feinstein Institute For Medical Research · R01 · FY2023 · GM
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$355,954Yuhang Zhang · University Of Cincinnati · R01 · FY2023 · CA
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
$355,927Ke Zhang · Northeastern University · R01 · FY2024 · CA
Connexin hemichannels in suppression of breast cancer bone metastasis
$355,918Jean X Jiang · University Of Texas Hlth Science Center · R01 · FY2016 · CA
Connexin hemichannels in suppression of breast cancer bone metastasis
$355,918Jean X Jiang · University Of Texas Hlth Science Center · R01 · FY2017 · CA
Immunotherapeutic targeting of MIF-dependent chaperone activity
$355,907Robert A. Mitchell · University Of Louisville · R01 · FY2023 · CA
Mechanisms of injury-induced pancreatic neoplasia
$355,906Agnieszka Beata Bialkowska · State University New York Stony Brook · R01 · FY2020 · DK